New challenges in the Long-COVID syndrome.

Abstract

Dear Editor, We read with great interest the recently published article in QJM by O’Brien et al. titled ‘Persistent diaphragmatic weakness and peripheral muscle weakness are associated with anosmia in the long-COVID syndrome’.1 We recently encountered a mania case with anosmia and ageusia in the long-coronavirus disease (COVID) syndrome. Example of effective-induced psychosis: the patient was healthy in the past, and his self-will had been enhanced after he was infected with COVID-19. After being infected with COVID-19, he suffered from insomnia for 8 days and meanwhile he lost his sense of taste and smell for 4 days and then he would be admitted to the hospital by the compulsory medical department. Post-admission Mental Status Exam (MSE) findings of a hyper-alert-oriented patient, who was collaborative but with a moderate level of psychomotor restlessness. He spoke loudly, talked endlessly, and thought he could ‘control everything’. He was cheerful and talkative, anxious and nervous, and felt energetic. In the acute stage, he accepted the mood stabilizer and an antipsychotic drug. After treatment, the patient's condition improved, and he was discharged from the hospital. He remained compliant with outpatient follow-up and medication.